Fabless semiconductor company designing RF/mixed-signal chips, mmWave 5G beamformers, and EMI-filtering components for wireless, defense, and connectivity applications.
AEON Biopharma filed a fresh S-1 for a biosimilar program while Mobix Labs amended its filing disclosing a going-concern warning -- a reminder this week's IPO pipeline is mostly small-cap, not AI infrastructure.
Jul 9, 2026Mobix Labs filed an S-1 registration statement with the SEC, adding a semiconductor name to a 2026 IPO pipeline increasingly stocked with companies tied to the AI and connectivity buildout. The filing is an early step that signals confidence chip-sector stories can find public-market demand in the current window.
Jun 18, 2026